Cerenome, Inc.

Cerenome, Inc.

0.71
USD
-0.24
(-24.77%)
-4.46EPS
Feb 25Next Earn

Important Dates

Cerenome, Inc.'s next confirmed earnings release is scheduled for February 25, 2027.

Earnings Date2/25/2027

Share Statistics

As of June 30, 2026, Cerenome, Inc. has 7.31M shares outstanding.

Shares Outstanding7.31M

Financial Position

As of June 30, 2026, Cerenome, Inc. maintains a current ratio of 1.37, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.81, indicating moderate leverage, while an interest coverage ratio of -8.42 demonstrates limited ability to service its debt obligations.

Current Ratio1.37
Quick Ratio1.23
Debt / Equity0.81
Interest Coverage-8.42

Financial Efficiency

Over the twelve months ended June 30, 2026, Cerenome, Inc. posted a negative return on equity (ROE) of -614.05, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -214.01, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 26.25, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-614.05
Return on Assets (ROA)-214.01
Employee Count26.25

Stock Price Statistics

USD

These figures are as of the close on November 16, 2026.

50-Day Moving Average1.66

Income Statement

USD

Over the twelve months ended June 30, 2026, Cerenome, Inc. generated - - in revenue and converted that into -26.09M in net income, yielding earnings per share of -4.46. EBITDA reached -25.94M, while operating income came in at -26.40M.

Operating Income-26.40M
Pretax Income-26.09M
Net Income-26.09M
EBITDA-25.94M
EBIT-26.40M
Earnings Per Share (EPS)-4.46

Balance Sheet

USD

As of June 30, 2026, Cerenome, Inc. holds 8.59M in cash and equivalents against 44,000.00 in total debt, resulting in a net debt position of -2.37M. Total book value stands at 5.46M, with working capital of 3.20M providing operational flexibility.

Cash & Cash Equivalents8.59M
Total Debt44,000.00
Net Debt-2.37M
Equity (Book Value)5.46M
Book Value Per Share0.75
Working Capital3.20M

Cash Flow

USD

Cerenome, Inc. produced -22.17M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.37M in capital expenditures, free cash flow totaled -23.55M - equivalent to -4.03 per share.

Operating Cash Flow-22.17M
Capital Expenditures-1.37M
Free Cash Flow-23.55M
FCF Per Share-4.03

Stock Splits

Cerenome, Inc.'s most recent stock split took place on April 2, 2026 with a 25:1 split ratio.

Last Split Date4/2/2026
Split Ratio25:1